Bone Biologics Corp (BBLG) Stock Price, Quote & News

Company Profile

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's lead medical device NELL-1/DBM, an osteopromotive recombinant protein that provides target-specific control over bone regeneration. It also develops NELL-1/DBM fusion device used in lumbar spinal fusion. The company's NELL-1 platform technology used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthoped...

Industry: Biotechnology

Sector: Healthcare

Phone: 781 552 4452

Website: www.bonebiologics.com

Address:

2 Burlington Woods Drive, Suite 100, Burlington, United States

WadehN21 Jan. 17 at 1:49 AM

$BBLG Tuesday..... rocket

0 · Reply

WadehN21 Jan. 16 at 6:31 PM

$BBLG I'm sensing news imminent

0 · Reply

VB_TrappinStockz Jan. 16 at 5:19 PM

$BBLG bubbling up 👀

0 · Reply

Gaussminigun Jan. 14 at 2:40 AM

$BBLG this isn't about BBL's? damn

0 · Reply

SxySarah Jan. 11 at 3:45 AM

$BBLG this is gonna get delisted soon.

0 · Reply

WadehN21 Jan. 9 at 3:47 PM

$BBLG

0 · Reply

joedoe007 Jan. 2 at 12:11 PM

$BBLG Can they not sell packaged bone 🦴 broth soups for everyone's good health ?? Nothing else seems to be working for this fulked up bone outfit , so maybe by selling bone 🍖 soups they can make a few extra $$$ and help da Bone shareholders maybe ???

0 · Reply

shakemystock Dec. 31 at 10:12 PM

$BBLG wow.. no bottom

0 · Reply

Love_To_Learn Dec. 30 at 1:03 PM

$BBLG manipulated your 1.58 an dhow its used note that longs !

0 · Reply

Streax Dec. 29 at 7:53 PM

$BBLG 80,000 short shares returned. Price goes down? 😆 volume shows 70,000 today. Did I miss something?

0 · Reply

Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook

Dec 23, 2025, 8:00 AM EST - 26 days ago

Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months

Sep 4, 2025, 7:00 AM EDT - 4 months ago

Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook

Sep 3, 2025, 7:00 AM EDT - 4 months ago

Bone Biologics to Participate in the H.C. Wainwright Global Investment Conference

Jun 30, 2025, 4:10 PM EDT - 7 months ago

Bone Biologics Announces Closing of $5.0 Million Public Offering

Jun 27, 2025, 10:23 AM EDT - 7 months ago

Why Is Bone Biologics Stock Surging On Friday?

Jun 27, 2025, 9:10 AM EDT - 7 months ago

Bone Biologics Announces Pricing of $5.0 Million Public Offering

Jun 27, 2025, 7:00 AM EDT - 7 months ago

Bone Biologics Files Patent Application for Bone Regeneration Technology

Jun 26, 2025, 4:20 PM EDT - 7 months ago

Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements

Jun 6, 2025, 8:00 AM EDT - 8 months ago

Bone Biologics Announces 1-for-6 Reverse Stock Split

Oct 21, 2024, 8:00 AM EDT - 1 year ago

Bone Biologics Appoints Phillip T. Meikle to its Board of Directors

Sep 4, 2024, 8:00 AM EDT - 1 year ago

Bone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 2, 2024, 8:00 AM EDT - 1 year ago

Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds

Jun 20, 2024, 8:00 AM EDT - 1 year ago

First Two Patients Treated in Pilot Clinical Study with Bone Biologics' NB1 Bone Graft Device in Spine Fusion

Mar 6, 2024, 4:15 PM EST - 2 years ago

Bone Biologics Announces Closing of $2.0 Million Public Offering

Mar 4, 2024, 9:15 AM EST - 2 years ago

Bone Biologics Announces Pricing of $2.0 Million Public Offering

Mar 1, 2024, 8:00 AM EST - 2 years ago

Bone Biologics Reports Progress With NB1 Clinical Program

Jan 11, 2024, 8:00 AM EST - 2 years ago

Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors

Dec 18, 2023, 8:00 AM EST - 2 years ago

Bone Biologics Announces 1-for-8 Reverse Stock Split

Nov 20, 2023, 12:38 PM EST - 2 years ago

Bone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Nov 16, 2023, 4:43 PM EST - 2 years ago

Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 26, 2023, 8:00 AM EDT - 2 years ago

Bone Biologics Provides Scientific Update on NB1 Bone Graft Device

Jun 21, 2023, 7:49 AM EDT - 2 years ago

Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month - Bone Biologics (NASDAQ:BBLG), Fresh2 Group (NASDAQ:FRES)

VTGN

Jun 15, 2023, 9:22 AM EDT - 2 years ago

Bone Biologics stock plummets more than 50% after stock offering prices at deep discount

Jun 14, 2023, 11:30 PM EDT - 2 years ago

Bone Biologics Prices $5.0 Million Underwritten Public Offering

Jun 6, 2023, 1:00 PM EDT - 2 years ago

Bone Biologics Effects 1-for-30 Reverse Stock Split

Apr 11, 2023, 8:00 AM EDT - 3 years ago

Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in Australia

Jan 26, 2023, 8:30 AM EST - 3 years ago

Bone Biologics Advances Preparations for NB1 Pilot Clinical Trial with Engagement of Contract Research Organization

Oct 25, 2022, 8:00 AM EDT - 3 years ago

Bone Biologics CEO Issues Letter to Stockholders

Oct 13, 2022, 9:00 AM EDT - 3 years ago

WallachBeth Capital Announces Closing of Bone Biologics $5,100,000 Underwritten Public Offering

Oct 12, 2022, 4:05 PM EDT - 3 years ago

Bone Biologics Announces Closing of $5,100,000 Underwritten Public Offering

Oct 7, 2022, 10:52 AM EDT - 3 years ago

CORRECTING and REPLACING Bone Biologics Prices $5,100,000 Underwritten Public Offering

Oct 7, 2022, 10:16 AM EDT - 3 years ago

WallachBeth Capital Announces Pricing of Bone Biologics $5,100,000 Underwritten Public Offering

Oct 7, 2022, 8:00 AM EDT - 3 years ago

Bone Biologics Prices $5,100,000 Million Underwritten Public Offering

Mar 23, 2022, 8:00 AM EDT - 4 years ago

Bone Biologics to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest

Mar 7, 2022, 7:00 AM EST - 4 years ago

Bone Biologics Enters into Supply Agreement with MTF Biologics for Demineralized Bone Matrix

Jan 10, 2022, 10:38 AM EST - 4 years ago

Why Are Bone Biologics Shares Surging On Monday?

Jan 5, 2022, 8:30 AM EST - 4 years ago

Bone Biologics to Present at the H.C. Wainwright BioConnect Virtual Conference

Oct 18, 2021, 8:30 AM EDT - 4 years ago

Bone Biologics Corp. Announces Closing of Public Offering and Uplisting to Nasdaq

Oct 15, 2021, 12:00 PM EDT - 4 years ago

WallachBeth Capital Announces Completion of Bone Biologics Corp. (NASDAQ: BBLG) $7.9 million Public Offering

Oct 13, 2021, 1:43 PM EDT - 4 years ago

WallachBeth Capital announces pricing of Bone Biologics Corp. (NASDAQ: BBLG) $7.9 million Public Offering and Uplisting to the NASDAQ Capital Market

Oct 13, 2021, 12:25 PM EDT - 4 years ago

Bone Biologics Corp. Announces Pricing of $7.9 million Public Offering; Uplisting to the Nasdaq Capital Market and Reverse Stock Split

WadehN21 Jan. 17 at 1:49 AM

$BBLG Tuesday..... rocket

0 · Reply

WadehN21 Jan. 16 at 6:31 PM

$BBLG I'm sensing news imminent

0 · Reply

VB_TrappinStockz Jan. 16 at 5:19 PM

$BBLG bubbling up 👀

0 · Reply

Gaussminigun Jan. 14 at 2:40 AM

$BBLG this isn't about BBL's? damn

0 · Reply

SxySarah Jan. 11 at 3:45 AM

$BBLG this is gonna get delisted soon.

0 · Reply

WadehN21 Jan. 9 at 3:47 PM

$BBLG

0 · Reply

joedoe007 Jan. 2 at 12:11 PM

0 · Reply

shakemystock Dec. 31 at 10:12 PM

$BBLG wow.. no bottom

0 · Reply

Love_To_Learn Dec. 30 at 1:03 PM

$BBLG manipulated your 1.58 an dhow its used note that longs !

0 · Reply

Streax Dec. 29 at 7:53 PM

$BBLG 80,000 short shares returned. Price goes down? 😆 volume shows 70,000 today. Did I miss something?

0 · Reply

Love_To_Learn Dec. 29 at 3:35 PM

$BBLG changing her movement off 1.51

0 · Reply

Love_To_Learn Dec. 29 at 3:33 PM

$BBLG me off 1.51* * ** * * * * *

0 · Reply

joedoe007 Dec. 27 at 3:46 AM

$BBLG Which bone is this company leadership's favorite bone? A dinosaur 🦕 bone 🦴 , a chicken bone 🍗 or a fish 🎣 bone ?? Why doesn't the company board build a Bone Museum and we shareholders can display our near worthless shares on the museum walls and we can also display stories of how shareholders got Frukked up buying this stonk ???

0 · Reply

Love_To_Learn Dec. 26 at 7:52 PM

$BBLG CHANGED SOMETHING FOR U 2 UPDATES *

0 · Reply

BandwidthBetsV2 Dec. 25 at 12:58 PM

$BBLG The opportunity set remains meaningful, but only if discipline keeps pace with ambition. The market is increasingly intolerant of delays that stretch credibility. Aligned incentives and governance can stabilize expectations. The path forward rewards patience only if progress turns repeatable.

1 · Reply

SxySarah Dec. 24 at 8:34 PM

$BBLG they should cause this “Boned biolgics group” bc that’s what they’ve done to their investors

1 · Reply

joedoe007 Dec. 24 at 6:08 PM

$BBLG Hello, I still did not get my Bone 🍖 broth soup yet How long does it take to cook me up a chicken bone broth soup ?? Also, my dog needs a bone too. Can the company give me a bone soup and a bone 🦴 for my dog ??

0 · Reply

YuGi0o25 Dec. 24 at 3:52 PM

$BBLG CYPH

0 · Reply

SxySarah Dec. 24 at 3:36 PM

$BBLG Sell this shit, I should have sold yesterday when it was above $2 again. this is a dog shit stock, that has very crappy catalysts, and only has funding till q2. their best catalyst was last july.

2 · Reply

Peak_Big Dec. 24 at 3:30 PM

$BBLG 🤭

0 · Reply

WillyBagman Dec. 24 at 3:08 PM

$BBLG Go back to 2.20 so I can break even. I promise to cash out like a good boy

0 · Reply

Love_To_Learn Dec. 24 at 2:27 PM

$BBLG I FEEL BAD COMPANY WAS GOING TO PUMP THIS NORTH OF 5 I STOPPED IT MAYBE I MAKE IT UP TO U AS I LOOP U DOWN LET US SEE

1 · Reply

Market Cap	3.20M
Revenue (ttm)	0.00
Net Income (ttm)	-4.11M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	142,800
Avg Vol	374,858
Day's Range	N/A - N/A
Shares Out	1.80M
Stochastic %K	74%
Beta	0.74
Analysts	Strong Buy
Price Target	$22.25